Immobilization of pamidronic acids on the nanotube surface of titanium discs and their interaction with bone cells
- Tae-Hyung Koo†1,
- Jyoti S Borah1,
- Zhi-Cai Xing†1,
- Sung-Mo Moon†2,
- Yongsoo Jeong†2 and
- Inn-Kyu Kang†1Email author
© Koo et al.; licensee Springer. 2013
Received: 29 January 2013
Accepted: 27 February 2013
Published: 12 March 2013
Self-assembled layers of vertically aligned titanium nanotubes were fabricated on a Ti disc by anodization. Pamidronic acids (PDAs) were then immobilized on the nanotube surface to improve osseointegration. Wide-angle X-ray diffraction, X-ray photoelectron microscopy, and scanning electron microscopy were employed to characterize the structure and morphology of the PDA-immobilized TiO2 nanotubes. The in vitro behavior of osteoblast and osteoclast cells cultured on an unmodified and surface-modified Ti disc was examined in terms of cell adhesion, proliferation, and differentiation. Osteoblast adhesion, proliferation, and differentiation were improved substantially by the topography of the TiO2 nanotubes, producing an interlocked cell structure. PDA immobilized on the TiO2 nanotube surface suppressed the viability of the osteoclasts and reduced their bone resorption activity.
KeywordsPamidronic acid TiO2 nanotubes Immobilization Surface modification Bone cell
The clinical success of orthopedic and dental implants depends on the interaction between the implanted surface and bone tissues and, consequently, their osseointegration . Titanium implants are used widely in orthopedic surgery and dentistry for their favorable biocompatibility and corrosion resistance [2, 3]. Surface modification of the implanted material is a critical factor for tissue acceptance and cell survival. Among three different crystalline phases of titania (anatase, rutile, and amorphous titania), anatase phase is more favorable for cell adhesion and proliferation due to lower surface contact angles and/or wettability . Several surface modification techniques, i.e., sol–gel techniques, chemical (alkali/acid) treatment, anodization, plasma spray, hydroxyapatite-coated surface, and self-assembled monolayers, have been developed and are currently used with the aim of enhancing the bioactivity of pure Ti surface [5–12].
Over the last decade, bisphosphonates (BPs) have attracted increasing attention as a surface modifier for orthopedic and dental implants. Bisphosphonates are stable pyrophosphates that prevent the loss of bone mass and are used widely to treat a range of diseases with excess bone resorption, such as bone metastasis, hypercalcemia of a malignancy, and Paget’s disease [13–16]. In orthopedic implants, the use of BP is expected to promote osteogenesis at the bone tissue/implant interface by inhibiting the activity of osteoclasts. BPs were reported to inhibit the differentiation of the osteoclast precursor and the resorptive activity of mature osteoclasts [17, 18]. Furthermore, BPs alter the morphology of osteoclasts, such as a lack of ruffled border and disruption of the actin ring, both in vitro and in vivo[19, 20]. García-Moreno et al. reported that BPs enhance the proliferation, differentiation, and bone-forming activity of osteoblasts directly . Recently, pamidronic acid, a nitrogen-containing bisphosphonate, was reported to conjugate the titanium surface and stimulate new bone formations around the implant both in vitro and in vivo, which contribute to the success of the implant technology [22, 23].
Besides chemical surface modifications, nanometric-scale surface topography and roughness of the biomaterial is also recognized as a critical factor for tissue acceptance and cell survival. Nanoscale topography affects cell adhesion and osteoblast differentiation [24–26]. It was reported that the fabrication of TiO2 nanotubes on titanium implants increased new bone formation significantly . To study the effect of the nanopore size on bone cell differentiation and proliferation, Park et al. used vertically aligned TiO2 nanotubes with six different diameters between 15 and 100 nm. They reported 15 nm to be the optimal length scale of the surface topography for cell adhesion and differentiation . TiO2 nanotubes can modulate the bone formation events at the bone-implant interface to reach a favorable molecular response and osseointegration . Immobilization of bone morphogenetic protein 2 (BMP-2) on TiO2 nanotubes stimulates both chondrogenic and osteogenic differentiation of mesenchymal stem cells (MSCs). Surface-functionalized TiO2 nanotubes with BMP-2 synergistically promoted the differentiation of MSCs [30, 31]. Furthermore, TiO2 nanotubes can control the cell fate and interfacial osteogenesis by altering their nanoscale dimensions, which have no dependency or side effects .
In this study, dual-surface modifications, i.e., nanometric-scale surface topography and chemical modification were examined to improve the osteogenesis of titanium implants. First, TiO2 nanotubes were fabricated on a Ti disc and pamidronic acid (PDA) was then immobilized on the nanotube surface. The behavior of osteoblasts and osteoclasts on the dual-surface modified and unmodified Ti disc surface were compared in terms of cell adhesion, proliferation, and differentiation to examine the potential for use in bone regeneration and tissue engineering. The motivation for the immobilization of PDA on nanotube surface was that PDA, a nitrogen-containing bisphosphonate, suppresses the osteoclast activity and improves the osseointegration of TiO2 nanotubes.
TiO2 nanotubes were prepared on a Ti disc surface by an anodizing method in a two-electrode (distance between the two electrodes is 7 cm) electrochemical cell with platinum foil as the counter electrode at a constant anodic potential of 25 V and current density of 20 V, in a 1 M H3PO4 (Merck, Whitehouse Station, NJ, USA) and 0.3 wt.% HF (Merck) aqueous solution with 100-rpm magnetic agitation at 20°C. The Ti disc specimen was commercially pure titanium grade IV. The specimen was cleaned ultrasonically in ethanol for 10 min and chemically polished in a 10 vol.% HF and 60 vol.% H2O2 solution for 3 min. All electrolytes were prepared from reagent-grade chemicals and deionized water. Heat treatment of TiO2 nanotubes was carried out for 3 h at 350°C in air. The morphology of the TiO2 nanotubes was observed by field emission scanning electron microscopy (FE-SEM; JSM 6700F, Jeol Co., Akishima-shi, Japan), and their crystal structure was analyzed by wide-angle X-ray diffraction (WAXD, PANalytical’s X’PertPro, Almelo, The Netherlands).
Immobilization of PDA on a nt-TiO2 disc
Osteoblastic cell culture
To examine the interaction of the surface-modified and unmodified TiO2 discs (Ti, nt-TiO2, and nt-TiO2-P) with osteoblasts (MC3T3-E1), the circular TiO2 discs were fitted to a 24-well culture dish and immersed in a Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal bovine serum (FBS; Gibco, Invitrogen, Carlsbad, CA, USA). Subsequently, 1 mL of the MC3T3-E1 cell solution (3 × 104 cells/mL) was added to the TiO2 disc surfaces and incubated in a humidified atmosphere containing 5% CO2 at 37°C for 4 h, 2 days, 3 days, and 4 days. After incubation, the supernatant was removed and the TiO2 discs were washed twice with phosphate-buffered silane (PBS; Gibco) and fixed in a 4% formaldehyde aqueous solution for 15 min. The samples were then dehydrated, dried in a critical-point drier, and sputter-coated with gold. The surface morphology of the TiO2 disc was observed by FE-SEM.
To examine the cytotoxic effects of PDA, after 2 days of culture, the osteoblast cells were suspended in PBS with a cell density of 1 × 105 to 1 × 106 cells/mL. Subsequently, 200 μL of a cell suspension was mixed with a 100-μL assay solution (10 μL calcein-AM solution (1 mM in DMSO) and 5 μL propidium iodide (1.5 mM in H2O) was mixed with 5 mL PBS) and incubated for 15 min at 37°C. The cells were then examined by fluorescence microscopy (Axioplan 2, Carl Zeiss, Oberkochen, Germany) with 490-nm excitation for the simultaneous monitoring of viable and dead cells.
The proliferation of osteoblasts on the Ti, nt-TiO2 and nt-TiO2-P discs was determined by a 3-(4,5-dimethylazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. Briefly, MC3T3-E1 osteoblasts were seeded at a concentration of 3 × 104 cells/mL on the Ti, nt-TiO2, and nt-TiO2-P disc surfaces, which fitted in a 24-well plate, and cell proliferation was monitored after 2 and 3 days of incubation. A MTT solution (50 μL, 5 mg/mL in PBS) was added to each well and incubated in a humidified atmosphere containing 5% CO2 at 37°C for 4 h. After removing the medium, the converted dye was dissolved in acidic isopropanol (0.04 N HCl-isopropanol) and kept for 30 min in the dark at room temperature. From each sample, the medium (100 μL) was taken, transferred to a 96-well plate, and subjected to ultraviolet measurements for the converted dye at a wavelength of 570 nm on a kinetic microplate reader (ELx800, Bio-Tek® Instruments, Inc., Highland Park, VT, USA).
The calcium deposition of MC3T3-E1 cells cultured was studied by Alizarin Red S staining. The cells were cultured for 15 days on Ti, nt-TiO2, and nt-TiO2-P discs under the same condition as described earlier. After incubation, the cells were washed with PBS, fixed in 10% formaldehyde for 30 min, and then triple washed with distilled water for 10 min. The samples were then treated with Alizarin Red S stain solution (1 mL) and incubated for 20 min. After washing the sample with distilled water four times, the digital images of the stained cultures were obtained (Nikon E 4500, Shinjuku, Japan).
Differentiation of macrophage
For osteoclastic differentiation, hematopoietic stem cells (HSC, name of cell line) at a cell density of 3 × 104 cells/mL were cultivated on Ti, nt-TiO2, and nt-TiO2-P discs in DMEM containing 10% FBS, 50 ng/mL mouse recombinant receptor activator of nuclear factor kappa-B ligand (RANKL), and 50 ng/mL macrophage colony-stimulating factors from mouse (m-CSF). The culture medium was changed every 2 days.
Tartrate-resistant acid phosphatase staining and solution assays
To analyze osteoclastic differentiation, the cells after 4 days of culture in the differentiation medium were washed once with PBS and fixed with 10% formalin (50 μL, neutral buffer) at room temperature for 5 min. After fixation, cells were washed with distilled water and incubated with a substrate solution (3 mg of chromogenic substrate with 5 mL tartrate-containing buffer (pH 5.0)) for 30 min at 37°C. The cell images were obtained by fluorescence microscopy.
For immunocytochemistry, the HSCs were cultivated in a differentiation medium and fixed and immunostained after 4 days with 4′,6-diamidino-2-phenylindole (DAPI) and (tetra-methyl rhodamine isothiocyanate)-phalloidin (TRICK), as described previously . Multinucleated cells containing more than three nuclei were considered differentiated osteoclast-like cells. The cell images were obtained by fluorescence microscopy. To confirm the viability of the differentiated macrophages on nt-TiO2 and nt-TiO2-P, the cells after 4 days of culture were stained with calcein-AM and propidium iodide, as described in the section for the osteoblastic cell culture, and examined by fluorescence microscopy.
Results and discussion
Crystal structure of TiO2 nanotubes and surface characterization of PDA-immobilized nt-TiO2
Chemical composition of nt-TiO 2 and surface-modified nt-TiO 2
Interaction of bone cells with the surface-modified TiO2 nanotubes
Adhesion, proliferation, and differentiation of osteoblasts
Differentiation of macrophages into osteoclasts and viability on nanotube surface
On the nt-TiO2 surface, differentiated osteoclasts stained with calcein-AM and propidium iodide showed a green color indicating the good viability of the cells. In contrast, along with green fluorescence, red fluorescence was also observed on the nt-TiO2-P surface, which suggests that some osteoclast cells died in contact with PDA (immobilized PDA did not show any cytotoxic effect on macrophage cells, Additional file 1: Figure S1). Osteoclasts normally destroy themselves by apoptosis, a form of cell suicide. PDA encourages osteoclasts to undergo apoptosis by binding and blocking the enzyme farnesyl diphosphate synthase in the mevalonate pathway . Thus, the viability of osteoclasts was suppressed on the nt-TiO2-P surface, leading to a decrease in bone resorption activity and an increase in osseointegration and bone maturation.
TiO2 nanotubes were successfully fabricated on Ti surface, and pamidronic acids were immobilized on the TiO2 nanotube surface. The adhesion and proliferation of osteoblasts were accelerated on the TiO2 nanotubes and pamidronic acid-conjugated TiO2 nanotubes compared to the Ti disc only. Macrophages were partially differentiated into osteoclasts by the addition of RANKL and m-CSF. The viability of osteoclasts was suppressed on the pamidronic acid-conjugated TiO2 nanotubes. This study has demonstrated that immobilization of PDA might be a promising method for the surface modification of TiO2 nanotube for use as dental and orthopedic implants. An in vivo study will be necessary to evaluate the potential of pamidronic acid-conjugated TiO2 nanotube as a therapeutic bone implant.
This study was supported by a grant (2010–0011125) and the Basic Research Laboratory Program (2011–0020264) of the Ministry of Education, Science and Technology of Korea.
- Masuda T, Yliheikkilä PK, Felton DA, Cooper LF: Generalizations regarding the process and phenomenon of osseointegration. Part I. In vivo studies. Int J Oral & Maxillofac Imp 1998, 13: 17–29.
- Liu Y, Li JP, Hunziker EB, Groot KD: Incorporation of growth factors into medical devices via biomimetic coatings. Phil Trans R Soc A 2006, 364: 233–248. 10.1098/rsta.2005.1685View Article
- Elias CN, Lima JHC, Valiev R, Meyers MA: Biomedical applications of titanium and its alloys. JOM 2008, 60: 46–49.View Article
- He J, Zhou W, Zhou X, Zhong X, Zhang X, Wan P, Zhu B, Chen W: The anatase phase of nanotopography titania plays an important role on osteoblasts cell morphology and proliferation. J Mater Sci Mater Med 2008, 19: 3465–3472. 10.1007/s10856-008-3505-3View Article
- Kim HW, Koh YH, Li LH, Lee S, Kim HE: Hydroxyapatite coating on titanium substrate with titania buffer layer processed by sol–gel method. Biomat 2004, 25: 2533–2538. 10.1016/j.biomaterials.2003.09.041View Article
- Tamilselvi S, Raghavendran HB, Srinivasan P, Rajendran NJ: In vitro and in vivo studies of alkali-and heat-treated Ti-6Al-7Nb and Ti-5Al-2Nb-1Ta alloys for orthopedic implants. Biomed Mater Res A 2009, 90: 380–386.View Article
- Guo J, Padilla RJ, Ambrose W, De Kok IJ, Cooper LF: The effect of hydrofluoric acid treatment of TiO2 grit blasted titanium implants on adherent osteoblast gene expression in vitro and in vivo. Biomat 2007, 28: 5418–5425. 10.1016/j.biomaterials.2007.08.032View Article
- Gong D, Grimes CA, Varghese OK, Hu WC, Singh RS, Chen ZJ: Titanium oxide nanotube arrays prepared by anodic oxidation. Mater Res 2001, 16: 3331–3334. 10.1557/JMR.2001.0457View Article
- Mello A, Hong Z, Rossi AM, Luan L, Farina M, Querido W: Osteoblast proliferation on hydroxyapatite thin coatings produced by right angle magnetron sputtering. Biomed Mater 2007, 2: 67–77. 10.1088/1748-6041/2/2/003View Article
- Daugaard H, Elmengaard B, Bechtold JE, Jensen T, Soballe KJ: The effect on bone growth enhancement of implant coatings with hydroxyapatite and collagen deposited electrochemically and by plasma spray. Biomed Mater Res A 2010, 92: 913–921.
- Nayaba SN, Jonesa FH, Olsena I: Modulation of the human bone cell cycle by calcium ion-implantation of titanium. Biomat 2007, 28: 38–44. 10.1016/j.biomaterials.2006.08.032View Article
- Guo YP, Zhou Y: Nacre coatings deposited by electrophoresis on Ti6Al4V substrates. Surf Coat Tech 2007, 201: 7505–7512. 10.1016/j.surfcoat.2007.02.021View Article
- Fleisch H: Bisphosphonates: mechanisms of action. Endcr Rev 1998, 19: 80–100. 10.1210/er.19.1.80View Article
- Russell RGG, Rogers MJ: Bisphosphonates: from the laboratory to the clinic and back again. Bone 1999, 25: 97–106. 10.1016/S8756-3282(99)00116-7View Article
- Douglas DL, Russell RGG, Kanis JA, Preston CJ, Preston FE, Preston MA, Woodhead JS: Effect of dichloromethylene diphosphonate in Paget’s disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease. Lancet 1980, 1: 10443–10447.
- Mundy GR, Yoneda TN: Bisphosphonates as anticancer drugs. Engl J Med 1998, 339: 398–400. 10.1056/NEJM199808063390609View Article
- Hughes DE, MacDonald BR, Russell RGG, Gowen MJ: Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. Clin Invest 1989, 83: 1930–1935. 10.1172/JCI114100View Article
- Carano A, Teitlebaum SL, Konsek JK, Schlesinger PH, Blair HCJ: Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. Clin Invest 1990, 85: 456–461. 10.1172/JCI114459View Article
- Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, Glub E, Rodan GAJ: Bisphosphonate action: alendronate localization in rat bone and effects on osteoclast ultrastructure. Clin Invest 1991, 88: 2095–2105. 10.1172/JCI115539View Article
- Murakami H, Takahashi N, Sasaki T, Udagawa N, Tanaka S, Nakamura I, Zhang D, Barbier A, Suda T: A possible mechanism of the specific action of bisphosphonates on osteoclasts: tildronate preferentially affects polarized osteoclasts having ruffled borders. Bone 1995, 17: 137–144. 10.1016/S8756-3282(95)00150-6View Article
- García-Moreno C, Serrano S, Nacher M, Farré M, Díez A, Mariñoso ML, Carbonell J, Mellibovsky L, Nogués X, Ballester J, Aubía J: Effect of alendronate on cultured normal human osteoblasts. Bone 1998, 22: 233–239. 10.1016/S8756-3282(97)00270-6View Article
- Yoshinari M, Oda Y, Ueki H, Yokose S: Immobilization of bisphosphonates on surface modified titanium. Biomat 2001, 22: 709–715. 10.1016/S0142-9612(00)00234-9View Article
- Kajiwara H, Yamaza T, Yoshinari M, Goto T, Iyama S, Atsutaa I, Kido MA, Tanaka TB: The bisphosphonate pamidronic acid on the surface of titanium stimulates bone formation around tibial implants in rats. Biomat 2005, 26: 581–587. 10.1016/j.biomaterials.2004.02.072View Article
- Mendonça G, Mendonça DB, Simões LG, Araújo AL, Leite ER, Duarte WR: The effects of implant surface nanoscale features on osteoblast specific gene expression. Biomat 2009, 30: 4053–4062. 10.1016/j.biomaterials.2009.04.010View Article
- Biggs MJ, Richards RG, Gadegaard N, McMurray RJ, Affrossman S, Wilkinson CDJ: Interactions with nanoscale topography: adhesion quantification and signal transduction in cells of osteogenic and multipotent lineage. Biomed Mater Res A 2009, 91: 195–208.View Article
- Shekaran A, Garcia AJ: Nanoscale engineering of extracellular matrix-mimetic bioadhesive surfaces and implants for tissue engineering. Biochim Biophys Acta 2011, 1810: 350–360. 10.1016/j.bbagen.2010.04.006View Article
- Oh S, Daraio C, Chen LH, Pisanic TR, Finones RR, Jin SJ: Significantly accelerated osteoblast cell growth on aligned TiO2 nanotubes. Biomed Mater Res A 2006, 78: 97–103.View Article
- Park J, Bauer S, Schlegel KA, Neukam FW, von der Mark K, Schmuki P: TiO2 nanotube surfaces: 15 nm—an optimal length scale of surface topography for cell adhesion and differentiation. Stem Cells 2009, 5: 666–671. 10.1016/j.stem.2009.11.011
- Wang N, Li H, Lü W, Li J, Wang J, Zhang Z, Liu Y: Effects of TiO2 nanotubes with different diameters on gene expression and osseointegration of implants in minipigs. Biomat 2011, 32: 6900–6911. 10.1016/j.biomaterials.2011.06.023View Article
- Park J, Bauer S, Pittrof A, Killian MS, Schlegel KA, Schmuki P, von der Mark K: Synergistic control of mesenchymal stem cell differentiation by nanoscale surface geometry and immobilized growth factors on TiO2 nanotubes. Small 2012, 8: 98–107. 10.1002/smll.201100790View Article
- Lai M, Cai K, Zhao L, Chen X, Hou Y, Yang Z: Surface functionalization of TiO2 nanotubes with bone morphogenic protein 2 and its synergistic effect on the differentiation of mesenchymal stem cells. Biomacromol 2011, 12: 1097–1105. 10.1021/bm1014365View Article
- Park J, Bauer S, von der Mark K, Schmuki P: Nanosize and vitality: TiO2 nanotube diameter direct cell fate. Nano Lett 2007, 7: 1686–1691. 10.1021/nl070678dView Article
- Muszynski KW, Ruscetti FW, Gooya JM, Linnekin DM, Keller JR: Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines. Stem Cells 1997, 5: 63–72.View Article
- Wagner CD, Riggs WM, Davis LE, Moulder JF: Handbook of X-ray Photoelectron Spectroscopy. Eden Prairie: Physical Electronics Division, Perkin-Elmer Corp; 1979:40.
- Kim HM, Chae WP, Chang KW, Chun S, Kim S, Jeong Y, Kang IKJ: Composite nanofiber mats consisting of hydroxyapatite and titania for biomedical applications. Biomed Mater Res B Appl Biomat 2010, 94B: 380–387.
- van Beek E, Cohen L, Leroy I, Ebetino F, Lowik C, Papapoulos S: Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates. Bone 2003, 33: 805–811. 10.1016/j.bone.2003.07.007View Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.